|
SFRS9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.48750000000953E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.356800E-04 |
| Normal-vs-Stage2 |
3.422000E-01 |
| Normal-vs-Stage3 |
1.996600E-04 |
| Normal-vs-Stage4 |
8.31339999951552E-07 |
| Stage1-vs-Stage2 |
2.779600E-01 |
| Stage1-vs-Stage3 |
3.376600E-01 |
| Stage1-vs-Stage4 |
8.961200E-03 |
| Stage2-vs-Stage3 |
1.423230E-01 |
| Stage2-vs-Stage4 |
1.340260E-02 |
| Stage3-vs-Stage4 |
1.296580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.14940000000153E-05 |
| Normal-vs-AfricanAmerican |
6.702600E-01 |
| Normal-vs-Asian |
2.281400E-03 |
| Caucasian-vs-AfricanAmerican |
1.227580E-01 |
| Caucasian-vs-Asian |
8.701800E-01 |
| AfricanAmerican-vs-Asian |
1.169790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.430490E-04 |
| Normal-vs-Female |
4.386500E-04 |
| Male-vs-Female |
2.830200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.839790E-04 |
| Normal-vs-Age(41-60Yrs) |
3.624000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.753800E-04 |
| Normal-vs-Age(81-100Yrs) |
5.436800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.321000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.441800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.780400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.759200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.031400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.772200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.625700E-04 |
| Classical-VS-Follicular |
4.452200E-01 |
| Classical-VS-Other |
3.001200E-01 |
| Classical-VS-Normal |
4.384200E-04 |
| Tall-VS-Follicular |
1.882560E-03 |
| Tall-VS-Other |
7.523800E-01 |
| Tall-VS-Normal |
3.52329999619982E-08 |
| Follicular-VS-Other |
3.849000E-01 |
| Follicular-VS-Normal |
1.515040E-01 |
| Other-VS-Normal |
1.440030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.120140E-02 |
| Normal-vs-N1 |
5.43599999458522E-08 |
| N0-vs-N1 |
4.230600E-04 |
|
|
